Part,  Chapter, Paragraph

 1   II,     5.  5.  3|     epilepsy revisited. Epileptic Disord 6:3-13.~Gaitatzis A, Carroll
 2   II,     5.  5.  3|          Parkinson’s disease. Mov Disord 13(4):626-632.~Anderson
 3   II,     5.  5.  3|           and specific foods. Mov Disord 14(1):21-27.~Andlin-Sobocki
 4   II,     5.  5.  3| populations of central Spain. Mov Disord 18(3):267-274.~Bergareche
 5   II,     5.  5.  3|       ascertainment of cases. Mov Disord 13(3):400-405.~Chrischilles
 6   II,     5.  5.  3|          Parkinson’s disease. Mov Disord 13(3):406-413.~Clarke CE,
 7   II,     5.  5.  3|          door-to-door survey. Mov Disord 17(2):242-249.~D’Alessandro
 8   II,     5.  5.  3|          lower Aragon, Spain. Mov Disord 14(4):596-604.~EuroPa Consortium (
 9   II,     5.  5.  3|          southeastern Sweden. Mov Disord. 14:28-37.~ ~Findley L,
10   II,     5.  5.  3|           the United Kingdom. Mov Disord 18(10):1139-1145.~Gasser
11   II,     5.  5.  3|          Parkinson’s disease. Mov Disord 22 Suppl 17:S343-350.~Global
12   II,     5.  5.  3|         international survey. Mov Disord 17(1):60-67.~Goetz CG, Stebbins
13   II,     5.  5.  3|         dominate at 15 years. Mov Disord 20(2):190-199~Hoehn M, Yahr
14   II,     5.  5.  3|       disease. Parkinsonism Relat Disord 8(5):297-309.~LePen C, Wait
15   II,     5.  5.  3|          Parkinson’s disease. Mov Disord 22(6):804-812.~Mutch WJ,
16   II,     5.  5.  3|       Bolivia. Parkinsonism Relat Disord 10(1):19-21.~Orphanet (2007):
17   II,     5.  5.  3|          Parkinson’s disease. Mov Disord 18(1):19-31.~Uitti RJ, Ahlskog
18  III,    10.  1.  3|            Int J Obes Relat Metab Disord 22 Suppl 2:S22-S29.~Bondy
19  III,    10.  1.  3|            Int J Obes Relat Metab Disord 23 Suppl 8: S1-S107.~Rehm